Choose your location
Select your country or region to view content specific to your country.
Choose your country
This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in each country.
Product News You can check out the latest product information
-
Obtained CE-IVD marking for Allplex™ Meningitis Panel Assays
Seegene has received CE-IVD mark under European Union on In Vitro Diagnostics Medical Devices for Allplex™ Meningitis Panel-V1, Allplex™ Meningitis-V2 Assay, Allplex™ Meningitis-B Assay. These assays are the multiplex one-step Real-time RT-PCR assay that detect and identifie 18 meningitis causative pathogens including 12 viruses and 6 bacteria. Based on Seegene’s proprietary MuDT™ technology, it allows reporting of each Ct value for multiple pathogens in a single channel without the melt curve analysis.
May 09, 2018｜ Allplex™ Meningitis Panel Assays
-
Obtained CE-IVD marking for Seeplex® Meningitis ACE Detection
Seeplex® Meningitis ACE Detection Detection of viruses and bacteria causing human meningitis Seegene's Seeplex® Meningitis ACE Detection has been notified at Germany CA (Competent Authorities). The CE mark will allow more opportunities for Seegene to market and sell within the European Union.
Jun 10, 2009｜ Seeplex® Meningitis ACE Detection